Penumbra
PEN
#1730
Rank
$11.54 B
Marketcap
$294.72
Share price
3.15%
Change (1 day)
18.32%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Revenue for Penumbra (PEN)

Revenue in 2025 (TTM): $1.33 Billion USD

According to Penumbra's latest financial reports the company's current revenue (TTM ) is $1.33 Billion USD. In 2024 the company made a revenue of $1.19 Billion USD an increase over the revenue in the year 2023 that were of $1.05 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Penumbra from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $1.33 B11.65%
2024 $1.19 B12.86%
2023 $1.05 B24.95%
2022 $0.84 B13.32%
2021 $0.74 B33.4%
2020 $0.56 B2.38%
2019 $0.54 B23.03%
2018 $0.44 B33.31%
2017 $0.33 B26.75%
2016 $0.26 B41.5%
2015 $0.18 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Inari Medical
NARI
$0.57 B-56.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
$1.47 B 10.75%๐Ÿ‡บ๐Ÿ‡ธ USA